226^th ENMC International Workshop:: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands

Affiliations

• ¹ Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: a.m.rus@lumc.nl.
• ² Unit of Medical Genetics, Department of Medical Sciences, University of Ferrara, Italy; Dubowitz Neuromuscular Unit, UCL, London.
• ³ Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL USA.
• ⁴ Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
• ⁵ Myology Institute, Department of Pharmacology and Therapeutics, University of Florida, Gainesville, FL, USA.
• ⁶ KTH School of Biotechnology, Royal Institute of Technology, Stockholm, Sweden.
• ⁷ University of Padova, Dept. of Neuroscience, Padova, Italy.
• ⁸ Parent Project Muscular Dystrophy, Washington, DC, USA.
• ⁹ Solid Biosciences, Cambridge, USA.
• ¹⁰ Parent Project Onlus, Genitori contro la Distrofia Muscolare di Duchenne & Becker ONLUS, Roma, Italy.
• ¹¹ SomaLogic Inc., Boulder, CO, USA.
• ¹² Universita di Ferrara, Dipartemento di Scienze Mediche, Sezione di Genetica Medica, Ferrara, Italy.
• ¹³ Sarepta Therapeutics, Cambridge, MA, USA.
• ¹⁴ Reveragen, Rockville, MD, USA.
• ¹⁵ Critical Path Institute, Duchenne Regulatory Science Consortium, Tucson, AZ, USA.
• ¹⁶ University of Oxford, Dept. Physiology, Anatomy and Genetics Oxford, UK.
• ¹⁷ Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
• ¹⁸ Marathon Pharmaceuticals, Northbrook, IL, USA.
• ¹⁹ Dubowitz Neuromuscular Centre, UCL Institute of Child Health, London, UK.
• ²⁰ Pfizer, Cambridge, MA, USA.
• ²¹ University of Essen, Dept. of Pediatric Neurology, Centre of NMD in childhood and adolescence, Essen, Germany.
• ²² The John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, University of Newcastle upon Tyne, UK.
• ²³ University of Florida, Dept. of Pharmacology and Therapeutics ARB R5/216, Dept. of Physiology, Gainesville, FL, USA.
• ²⁴ Summit plc, Abingdon, UK.
• ²⁵ Muscular Dystrophy UK, London, UK.
• ²⁶ Duchenne Parent Project, UPPMD, Amsterdam, The Netherlands.
• ²⁷ PTC Therapeutics, South Plainfield, NJ, USA.